FI930821L - Bestaemning av maolkomponenter - Google Patents

Bestaemning av maolkomponenter Download PDF

Info

Publication number
FI930821L
FI930821L FI930821A FI930821A FI930821L FI 930821 L FI930821 L FI 930821L FI 930821 A FI930821 A FI 930821A FI 930821 A FI930821 A FI 930821A FI 930821 L FI930821 L FI 930821L
Authority
FI
Finland
Prior art keywords
maolkomponenter
bestaemning
Prior art date
Application number
FI930821A
Other languages
English (en)
Finnish (fi)
Other versions
FI930821A7 (fi
FI930821A0 (fi
Inventor
Robert A Levine
Stephen C Wardlaw
Rodolfo Rodriguez
Judith Britz
Thomas J Mercolino
Original Assignee
Robert A Levine
Stephen C Wardlaw
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert A Levine, Stephen C Wardlaw, Becton Dickinson Co filed Critical Robert A Levine
Publication of FI930821A0 publication Critical patent/FI930821A0/fi
Publication of FI930821A7 publication Critical patent/FI930821A7/fi
Publication of FI930821L publication Critical patent/FI930821L/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FI930821A 1992-02-25 1993-02-24 Bestaemning av maolkomponenter FI930821L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84197692A 1992-02-25 1992-02-25

Publications (3)

Publication Number Publication Date
FI930821A0 FI930821A0 (fi) 1993-02-24
FI930821A7 FI930821A7 (fi) 1993-08-26
FI930821L true FI930821L (fi) 1993-08-26

Family

ID=25286232

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930821A FI930821L (fi) 1992-02-25 1993-02-24 Bestaemning av maolkomponenter

Country Status (17)

Country Link
US (1) US5593848A (enExample)
EP (1) EP0557595B1 (enExample)
JP (1) JP2925105B2 (enExample)
CN (1) CN1091521A (enExample)
AT (1) ATE155889T1 (enExample)
AU (1) AU662571B2 (enExample)
BR (1) BR9300639A (enExample)
CA (1) CA2090282A1 (enExample)
DE (1) DE69221118T2 (enExample)
DK (1) DK0557595T3 (enExample)
ES (1) ES2106121T3 (enExample)
FI (1) FI930821L (enExample)
GR (1) GR3024970T3 (enExample)
MX (1) MX9300965A (enExample)
NO (1) NO930649L (enExample)
RU (1) RU2116068C1 (enExample)
TW (1) TW246716B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
AU9233698A (en) * 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US6911315B2 (en) * 1997-11-24 2005-06-28 David L. Rimm Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
ID27131A (id) * 1998-06-26 2001-03-01 Pfizer Prod Inc Proses yang lebih baik untuk membuat hasil adisi basa schiff dari amina dengan o-hidroksi aldehida dan komposisi materi yang didasarkan padanya
GB0021303D0 (en) * 2000-08-30 2000-10-18 Medinnova Sf Use
WO2004039962A2 (en) * 2002-10-30 2004-05-13 Pointilliste, Inc. Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
WO2005016141A1 (en) * 2003-07-09 2005-02-24 California Pacific Medical Center Remote detection of substance delivery to cells
US7996825B2 (en) * 2003-10-31 2011-08-09 Hewlett-Packard Development Company, L.P. Cross-file inlining by using summaries and global worklist
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
CN102047114B (zh) 2008-04-02 2014-10-29 艾博特健康公司 在成分检验中的自校准梯度稀释以及在薄膜样本中执行的梯度稀释设备
ES2548133T3 (es) * 2008-04-09 2015-10-14 Abbott Point Of Care, Inc. Método de detección de niveles muy bajos de analito en una muestra fluida de película delgada contenida en una cámara de pequeño espesor
FR2965273B1 (fr) * 2010-09-29 2015-07-17 Centre Nat Rech Scient Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en) 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
CN102788879B (zh) * 2011-05-20 2015-04-01 常州康卫生物技术有限公司 一种生物检测试剂
WO2016179530A1 (en) * 2015-05-06 2016-11-10 Seracare Life Sciences, Inc. Liposomal preparations for non-invasive-prenatal or cancer screening

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors
US4027660A (en) * 1976-04-02 1977-06-07 Wardlaw Stephen C Material layer volume determination
US4181609A (en) * 1977-12-20 1980-01-01 Levine Robert A Blood constituents testing method
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US4332785A (en) 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) * 1982-01-27 1986-01-31 Yissum Res Dev Co Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
JPS6035267A (ja) * 1983-08-05 1985-02-23 Fuji Photo Film Co Ltd 多項目免疫検査法
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
EP0241042A3 (en) * 1986-04-11 1988-05-04 Hitachi, Ltd. A method for cell analysis
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) * 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US5017472A (en) * 1987-09-09 1991-05-21 Bankert Richard B Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
GB2239197B (en) * 1989-12-22 1993-10-06 Syntex Inc Method for separating components in a mixture
JPH03249561A (ja) * 1990-02-28 1991-11-07 Toshiba Corp 免疫分析試薬

Also Published As

Publication number Publication date
AU662571B2 (en) 1995-09-07
DE69221118T2 (de) 1998-02-26
TW246716B (enExample) 1995-05-01
DE69221118D1 (de) 1997-09-04
NO930649D0 (no) 1993-02-24
FI930821A7 (fi) 1993-08-26
EP0557595A2 (en) 1993-09-01
GR3024970T3 (en) 1998-01-30
CN1091521A (zh) 1994-08-31
CA2090282A1 (en) 1993-08-26
NO930649L (no) 1993-08-26
BR9300639A (pt) 1993-08-31
RU2116068C1 (ru) 1998-07-27
EP0557595A3 (enExample) 1993-11-10
ATE155889T1 (de) 1997-08-15
JP2925105B2 (ja) 1999-07-28
EP0557595B1 (en) 1997-07-23
DK0557595T3 (da) 1997-12-29
FI930821A0 (fi) 1993-02-24
MX9300965A (es) 1994-08-31
US5593848A (en) 1997-01-14
JPH0821833A (ja) 1996-01-23
ES2106121T3 (es) 1997-11-01
AU2983692A (en) 1993-08-26

Similar Documents

Publication Publication Date Title
FI934804L (fi) Indirekt fluorescensanalys av blodprov
FI934648A7 (fi) Foerfarande foer foergasning av avfallsaemnen innehaollande braennbara bestaondsdelar
FI933104A0 (fi) Foerfarande foer delignifiering av kemisk pappersmassa
FI924590A0 (fi) Foerfarande foer framstaellning av laekemedelskorn
FI932012L (fi) Foerfarande foer framstaellning av arylpiperazinyl-heterocykliska foereningar
FI925925L (fi) Foerfarande foer framstaellning av valbart hydrerade osmaeltbara polysackarider
FI934013L (fi) Foerstaerkning av immunreaktion
FI933103A0 (fi) Foerfarande foer blekning av kemisk pappersmassa
FI930281L (fi) Reaktivering av hydroformyleringskatalysatorer
FI931121L (fi) Bockningspress foer framstaellning av boejda glasrutor
FI932726A0 (fi) Foerfarande foer framstaellning av nickelhydroxid
FI931032L (fi) Foerfarande foer framstaellning av klavulansyrasalter
FI932675A0 (fi) Rullmaskin foer rullning av en pappers- eller kartongbana
FI931553L (fi) Foerfarande foer utvinning av enzymer fraon proenzymer
FI933955L (fi) Foerfarande foer framstaellning av substituerade indanoner
FI933192A0 (fi) Anordning foer kultivering av mikroorganismer
FI934900L (fi) Mellandestillatkompostioner av raoolja
FI934291A0 (fi) Maetning av restblaeck
FI932322A7 (fi) Braensleelement foer en kaernreaktor av laettvattentyp
FI932714L (fi) Propellermodul foer indikering av stroemning
FI932016A7 (fi) Anordning foer pervaporering av vaetskor
FI933976L (fi) Foerfarande foer recyklering av silikonbelagt papper
FI931110A0 (fi) Flerskiktfolier av kopolyamider
FI932570A7 (fi) Foerfarande foer framstaellning av 2-oxo-1-piperidinylderivat
FI931712A0 (fi) Foerfarande foer utvinning av en polymeriserbar vaerdeaemnesfraktion